PBAC moves to reassure on biosimilars

The PBAC has issued a statement intending to reassure the public about the safety of biosimilar copies of biologic drugs, in a bid to stamp out “misinformation” which could slow progress in biosimilars. The PBAC recently recommended allowing biologics to be substituted with biosimilar drugs by clinicians and pharmacists if the biosimilar is found to